Eric H. Meuleman

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Effectiveness of Preoperative Depilation of the Urethral Donor Site for Phalloplasty: Neourethral Hair Growth and its Effects on Voiding.

Effectiveness of Preoperative Depilation of the Urethral Donor Site for Phalloplasty: Neourethral Hair Growth and its Effects on Voiding.

Journal: European urology focus

Published: December 02, 2018

Erectile dysfunction from a urological perspective

Erectile dysfunction from a urological perspective

Journal: Nederlands tijdschrift voor geneeskunde

Published: July 25, 2018

The multilayered structure of the human corpus spongiosum.

The multilayered structure of the human corpus spongiosum.

Journal: Histology and histopathology

Published: July 10, 2018

Bladder necrosis: 'A man without a bladder'.

Bladder necrosis: 'A man without a bladder'.

Journal: BMJ case reports

Published: February 19, 2018

A Longitudinal Study of Motivations Before and Psychosexual Outcomes After Genital Gender-Confirming Surgery in Transmen.

A Longitudinal Study of Motivations Before and Psychosexual Outcomes After Genital Gender-Confirming Surgery in Transmen.

Journal: The journal of sexual medicine

Published: July 31, 2017

Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).

Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).

Journal: The journal of sexual medicine

Published: December 14, 2016

Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.

Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.

Journal: BJU international

Published: July 14, 2016

Effects of long-term oral testosterone undecanoate therapy on urinary symptoms: data from a 1-year, placebo-controlled, dose-ranging trial in aging men with symptomatic hypogonadism.

Effects of long-term oral testosterone undecanoate therapy on urinary symptoms: data from a 1-year, placebo-controlled, dose-ranging trial in aging men with symptomatic hypogonadism.

Journal: The aging male : the official journal of the International Society for the Study of the Aging Male

Published: June 02, 2015

Peyronie's disease

Peyronie's disease

Journal: Nederlands tijdschrift voor geneeskunde

Published: July 10, 2014

Risk of disease flare with LHRH agonist therapy in men with prostate cancer: myth or fact?

Risk of disease flare with LHRH agonist therapy in men with prostate cancer: myth or fact?

Journal: Urologic oncology

Published: March 12, 2014

Development of an in vitro model to measure bioactivity of botulinum neurotoxin A in rat bladder muscle strips.

Development of an in vitro model to measure bioactivity of botulinum neurotoxin A in rat bladder muscle strips.

Journal: BMC urology

Published: March 04, 2014

Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging study.

Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging study.

Journal: The aging male : the official journal of the International Society for the Study of the Aging Male

Published: April 16, 2013

Showing 1-12 of 18

Last Updated: 09/26/2026